2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Balance between Interleukin 17-Secreting T Helper Cells and Regulatory T Cells after Renal Transplantation: Relation to Graft Function and Survival, The

H. El Aggan, N. Farahat, M. Emara
Banff Scoring in Early and Late Acute Cellular Rejection Predicts Graft Survival

J. Krisl, R. Alloway, A. Shields, D. Witte, E. Woodle
Barriers for Seniors To Get Listed for Kidney Transplantation

S. Bolourani, L. Lindquist, B. Lapin, D. Ladner
Baseline Mean Pulmonary Artery Pressure Is an Independent Predictor of Acute Kidney Injury after Lung Transplanation

B. Stephany, J. Thapa, E. Wehbe
Behavior of ADAMTS13 and Von Willebrand Factor Levels in Patients after Living Donor Liver Transplantation

N. Takahashi, H. Wada, M. Usui, Y. Iizawa, R. Sato, T. Hujii, A. Tanemura, N. Kuriyama, Y. Azumi, I. Osawa, M. Kishiwada, S. Mizuno, H. Sakurai, M. Tabata, S. Isaji
Behavioral Reference Points in Organ Utilization

K. Schnier, V. Sadiraj, J. Cox, N. Turgeon
Belatacept Post-Approval Implementation: A Large Single Center Experience

A. Adams, C. Garrett, A. Chami, M. Harler, S. Pastan, A. Kirk, T. Pearson, C. Larsen
Belimumab (Anti-BAFF/BLyS) Effective in a Case of Resistant Antibody Mediated Rejection

N. Leca, K. Muczynski
Benefits of a Robotic Donor Nephrectomy Program: A Series of 100 Consecutive Donors

A. Cohen, D. Williams, H. Bohorquez, D. Bruce, I. Carmody, T. Reichman, G. Loss
Bilirubin Improvement Correlates with 90-Day Survival with Use of the ELAD® System in a Randomized, Controlled Study of Subjects with Acute Alcoholic Hepatitis or Acute Decompensation of Cirrhosis

L. Teperman, The ELAD Study Group

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z